MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 21.03.2026
Aurora Cannabis ROCE 2011-2026 | ACB
ROCE Jährlich Aurora Cannabis
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | -23.09 | -6.28 | -4.42 | -3.22 | -44.14 | -71.3 | -22.65 | - | - | - |
Alle Zahlen in CAD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -3.22 | -71.3 | -25.01 |
ROCE anderer Aktien in der Arzneimittelhersteller
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
-79.15 | - | 7.5 % | $ 6.35 M |  USA |
 |
Alimera Sciences
ALIM
|
-4.18 | - | - | $ 142 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
267.43 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
121.85 | - | 10.11 % | $ 58.2 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3101.1 | - | 0.86 % | $ 117 M | USA |
 |
China Pharma Holdings
CPHI
|
-59.23 | $ 0.63 | - | $ 11 M |  China |
 |
Catalent
CTLT
|
-20.78 | - | - | $ 11.5 B | USA |
 |
Athenex
ATNX
|
1076.15 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-57.41 | - | - | $ 2.06 B |  France |
 |
Cronos Group
CRON
|
-10.43 | $ 2.54 | 0.79 % | $ 1.33 B |  Canada |
 |
DURECT Corporation
DRRX
|
-249.5 | - | - | $ 50.1 M | USA |
 |
Emergent BioSolutions
EBS
|
-111.87 | $ 8.03 | -0.25 % | $ 411 M | USA |
 |
Endo International plc
ENDP
|
7.34 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-184.26 | - | - | $ 36.6 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-39.6 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-85.61 | - | 2.45 % | $ 38.1 M | Canada |
 |
Cumberland Pharmaceuticals
CPIX
|
-8.06 | $ 3.17 | 3.77 % | $ 44.6 M | USA |
 |
Bausch Health Companies
BHC
|
-94.23 | $ 4.97 | -2.74 % | $ 1.81 B | Canada |
 |
Pacira BioSciences
PCRX
|
-9.43 | $ 22.73 | 0.35 % | $ 1.05 B | USA |
 |
Harrow Health
HROW
|
58.18 | $ 35.35 | 3.96 % | $ 1.3 B | USA |
 |
OptiNose
OPTN
|
26.27 | - | - | $ 1.08 B | USA |
 |
Evolus
EOLS
|
141.36 | $ 4.62 | -1.39 % | $ 298 M | USA |
 |
Rockwell Medical
RMTI
|
-31.33 | $ 1.05 | 2.94 % | $ 24.5 M | USA |
 |
Solid Biosciences
SLDB
|
-90.02 | $ 6.79 | -4.97 % | $ 594 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
34.66 | - | -39.89 % | $ 27.7 M | USA |
 |
Sundial Growers
SNDL
|
-68.48 | $ 1.36 | - | $ 3.37 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
-84.11 | $ 2.34 | -8.24 % | $ 2.9 M | USA |
 |
Relmada Therapeutics
RLMD
|
-68.31 | $ 6.08 | 3.67 % | $ 240 M | USA |
 |
OrganiGram Holdings
OGI
|
-35.84 | $ 1.37 | 0.37 % | $ 402 M | Canada |
 |
Tilray
TLRY
|
-41.31 | $ 6.43 | -0.31 % | $ 3.97 B | Canada |
 |
PetIQ
PETQ
|
5.46 | - | 1.64 % | $ 400 M | USA |
 |
PLx Pharma
PLXP
|
-114.37 | - | -27.8 % | $ 2.56 M | USA |
 |
ProPhase Labs
PRPH
|
32.97 | - | - | $ 5.07 M | USA |
 |
Veru
VERU
|
-114.23 | $ 2.3 | - | $ 310 M | USA |
 |
Jupiter Wellness
JUPW
|
-116.71 | - | - | $ 33.6 M | USA |
 |
Viatris
VTRS
|
3.74 | $ 13.44 | 1.09 % | $ 16.1 B | USA |
 |
Radius Health
RDUS
|
21.53 | - | - | $ 1.42 B | USA |
 |
Lannett Company
LCI
|
70.21 | - | 1.15 % | $ 7.11 M | USA |
 |
SCYNEXIS
SCYX
|
-32.55 | $ 0.87 | -0.59 % | $ 43.4 M | USA |
 |
TherapeuticsMD
TXMD
|
-29.1 | $ 2.29 | -1.07 % | $ 23.9 M | USA |
 |
cbdMD
YCBD
|
-235.96 | $ 0.77 | 1.21 % | $ 3.32 M | USA |
 |
Organogenesis Holdings
ORGO
|
-0.49 | $ 2.4 | -2.83 % | $ 316 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-29.88 | - | - | $ 193 M | Canada |
 |
Perrigo Company plc
PRGO
|
-14.92 | $ 9.74 | 1.78 % | $ 1.35 B | USA |
 |
Canopy Growth Corporation
CGC
|
-24.04 | $ 0.95 | -1.5 % | $ 102 M | Canada |
 |
Assertio Holdings
ASRT
|
-22.92 | $ 16.05 | 14.64 % | $ 103 M | USA |
 |
Recro Pharma
REPH
|
-6.09 | - | -4.76 % | $ 65.3 M | USA |
 |
Tricida
TCDA
|
-70162.39 | - | - | $ 3.25 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-76.25 | - | - | $ 55.5 M | USA |